Modified Vaccinia Ankara (MVA) Vaccine Study

Clinical trial NCT01256853 · COMPLETED

Trial details

NCT number: NCT01256853
Sponsor: Chinese University of Hong Kong
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Nasopharyngeal Neoplasms Epstein-Barr Virus Infections

Start date: 2006-09-01
Primary completion: 2010-09-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.